Skip to main content
. Author manuscript; available in PMC: 2014 Nov 21.
Published in final edited form as: Anticancer Agents Med Chem. 2012 Dec;12(10):1221–1238. doi: 10.2174/187152012803833080

Figure 1.

Figure 1

IL-6 magnifies the inflammatory response through its soluble receptor. Release of the sIL-6R acts to amplify the inflammatory response by making cells lacking mIL-6R responsive to IL-6. The resulting sustained inflammatory response paves way for the progression from acute to chronic inflammation and could ultimately lead to colitis-associated cancer.